메뉴 건너뛰기




Volumn 50, Issue 5, 2008, Pages 419-427

Chronic non-communicable diseases in Mexico: Epidemiologic synopsis and integral prevention;Las enfermedades crónicas no transmisibles en México: Sinopsis epidemiológica y prevención integral

Author keywords

Cholesterol; Diabetes mellitus; HDL; Mexico; Obesity; Prevention control

Indexed keywords


EID: 57449102177     PISSN: 00363634     EISSN: 16067916     Source Type: Journal    
DOI: 10.1590/S0036-36342008000500015     Document Type: Review
Times cited : (111)

References (66)
  • 3
    • 0037048694 scopus 로고    scopus 로고
    • Improving primary care for patients with chronic illness
    • Bodenheimer T, Wagner E, Grumbach K. Improving primary care for patients with chronic illness. JAMA 2002;288:1775-1779.
    • (2002) JAMA , vol.288 , pp. 1775-1779
    • Bodenheimer, T.1    Wagner, E.2    Grumbach, K.3
  • 5
    • 33744983252 scopus 로고    scopus 로고
    • Management of the metabolic syndrome as a strategy for preventing the macrovascular complications of type 2 diabetes: Controversial issues
    • Aguilar-Salinas CA, Mehta R, Rojas R, Gomez-Perez FJ, Olaiz G, Rull JA. Management of the metabolic syndrome as a strategy for preventing the macrovascular complications of type 2 diabetes: controversial issues. Curr Diab Rev 2005;1:145-158.
    • (2005) Curr Diab Rev , vol.1 , pp. 145-158
    • Aguilar-Salinas, C.A.1    Mehta, R.2    Rojas, R.3    Gomez-Perez, F.J.4    Olaiz, G.5    Rull, J.A.6
  • 7
    • 33751366229 scopus 로고    scopus 로고
    • Sustained reduction in the incidence of type 2 diabetes by lifestyle intervention: Follow-up of the Finnish Diabetes Prevention Study
    • Lindstr_m J, Ilanne-Parikka P, Peltonen M, Aunola S, Eriksson J, Hemio K, et al. Sustained reduction in the incidence of type 2 diabetes by lifestyle intervention: follow-up of the Finnish Diabetes Prevention Study. Lancet 2006;368:1673-1679.
    • (2006) Lancet , vol.368 , pp. 1673-1679
    • Lindstrom, J.1    Ilanne-Parikka, P.2    Peltonen, M.3    Aunola, S.4    Eriksson, J.5    Hemio, K.6
  • 9
    • 0037031061 scopus 로고    scopus 로고
    • MRC/BHF Heart Protection Study of cholesterol lowering with simvastatin in 20536 high-risk individuals: A randomized placebo controlled trial
    • Heart Protection Study Collaborative Group
    • Heart Protection Study Collaborative Group. MRC/BHF Heart Protection Study of cholesterol lowering with simvastatin in 20536 high-risk individuals: a randomized placebo controlled trial. Lancet 2002;360:7-22.
    • (2002) Lancet , vol.360 , pp. 7-22
  • 10
    • 0034700790 scopus 로고    scopus 로고
    • Effects of ramipril on cardiovascular and microvascular outcomes in people with diabetes mellitus: Results of the HOPE study and MICRO-HOPE substudy
    • Heart Outcomes Prevention Evaluation Study Investigators
    • Heart Outcomes Prevention Evaluation Study Investigators. Effects of ramipril on cardiovascular and microvascular outcomes in people with diabetes mellitus: results of the HOPE study and MICRO-HOPE substudy. Lancet 2000;355:253-259.
    • (2000) Lancet , vol.355 , pp. 253-259
  • 11
    • 0034879933 scopus 로고    scopus 로고
    • High prevalence of low HDL cholesterol concentrations and mixed hyperlipidemia in a Mexican nation wide survey
    • Aguilar-Salinas CA, Olaiz G, Valles V, Rios JM, Gomez-Perez FJ, et al. High prevalence of low HDL cholesterol concentrations and mixed hyperlipidemia in a Mexican nation wide survey. J Lip Res 2001;42:1298-1307.
    • (2001) J Lip Res , vol.42 , pp. 1298-1307
    • Aguilar-Salinas, C.A.1    Olaiz, G.2    Valles, V.3    Rios, J.M.4    Gomez-Perez, F.J.5
  • 14
    • 57449084898 scopus 로고    scopus 로고
    • Olaiz G, Rojas R, Barquera S, Shamah T, Aguilar-Salinas C, Cravioto P, et al. Encuesta Nacional de Salud 2000. La salud de los adultos. Cuernavaca, Morelos: Instituto Nacional de Salud Pública, 2003.
    • Olaiz G, Rojas R, Barquera S, Shamah T, Aguilar-Salinas C, Cravioto P, et al. Encuesta Nacional de Salud 2000. La salud de los adultos. Cuernavaca, Morelos: Instituto Nacional de Salud Pública, 2003.
  • 16
    • 19144367908 scopus 로고    scopus 로고
    • Applicability of the National Cholesterol Education Program III (NCEP-III) Guidelines for treatment of dyslipidemia in a non-Caucasian population: A Mexican Nation-Wide Survey
    • Rojas R, Aguilar-Salinas CA, Gomez-Perez FJ, Valles V, Franco A, Olaiz G, et al. Applicability of the National Cholesterol Education Program III (NCEP-III) Guidelines for treatment of dyslipidemia in a non-Caucasian population: a Mexican Nation-Wide Survey. Rev Inves Clin 2005;57:28-37.
    • (2005) Rev Inves Clin , vol.57 , pp. 28-37
    • Rojas, R.1    Aguilar-Salinas, C.A.2    Gomez-Perez, F.J.3    Valles, V.4    Franco, A.5    Olaiz, G.6
  • 17
    • 0035897696 scopus 로고    scopus 로고
    • evaluation and treatment of high blood cholesterol in adults. Executive summary of the third report of the national cholesterol education program (NCEP) expert panel on detection, evaluation and treatment of high blood cholesterol in adults (adult treatment panel III)
    • Expert Panel on detection
    • Expert Panel on detection, evaluation and treatment of high blood cholesterol in adults. Executive summary of the third report of the national cholesterol education program (NCEP) expert panel on detection, evaluation and treatment of high blood cholesterol in adults (adult treatment panel III). JAMA 2001;285:2486-2497.
    • (2001) JAMA , vol.285 , pp. 2486-2497
  • 19
    • 0242284429 scopus 로고    scopus 로고
    • International Diabetes Federation, 2da ed. Bruselas, Bélgica: International Diabetes Federation
    • International Diabetes Federation. Diabetes Atlas. 2da ed. Bruselas, Bélgica: International Diabetes Federation, 2003.
    • (2003) Diabetes Atlas
  • 21
    • 0037092913 scopus 로고    scopus 로고
    • Cost-effectiveness of intensive glycemic control, intensified hypertension control, and serum cholesterol reduction for type 2 diabetes
    • The CDC Diabetes Cost-effectiveness Group
    • The CDC Diabetes Cost-effectiveness Group. Cost-effectiveness of intensive glycemic control, intensified hypertension control, and serum cholesterol reduction for type 2 diabetes. JAMA 2002;287:2542-2551.
    • (2002) JAMA , vol.287 , pp. 2542-2551
  • 22
    • 0347133334 scopus 로고    scopus 로고
    • Poor control of risk factors for vascular disease among adults with previously diagnosed diabetes
    • Saydah S, Fradkin J, Cowie C. Poor control of risk factors for vascular disease among adults with previously diagnosed diabetes. JAMA 2004;291:335-342.
    • (2004) JAMA , vol.291 , pp. 335-342
    • Saydah, S.1    Fradkin, J.2    Cowie, C.3
  • 24
    • 30944460687 scopus 로고    scopus 로고
    • Managing abnormal blood lipids. A collaborative approach
    • Fletcher B, Berra K, Ades P, Braun L, Burke L, et al. Managing abnormal blood lipids. A collaborative approach. Circulation 2005;112:3184-3209.
    • (2005) Circulation , vol.112 , pp. 3184-3209
    • Fletcher, B.1    Berra, K.2    Ades, P.3    Braun, L.4    Burke, L.5
  • 25
    • 57449106665 scopus 로고    scopus 로고
    • Clinical Guidelines Task Force
    • International Diabetes Federation, Bruselas, Bélgica: International Diabetes Federation
    • International Diabetes Federation. Clinical Guidelines Task Force. Guía global para la diabetes tipo 2. Bruselas, Bélgica: International Diabetes Federation, 2006.
    • (2006) Guía global para la diabetes tipo , vol.2
  • 27
    • 27544508598 scopus 로고    scopus 로고
    • Preventing chronic diseases: How many lives can we save
    • Strong K, Mathers C, Leeder S, Beaglehole R. Preventing chronic diseases: how many lives can we save. Lancet 2005;366:1578-1582.
    • (2005) Lancet , vol.366 , pp. 1578-1582
    • Strong, K.1    Mathers, C.2    Leeder, S.3    Beaglehole, R.4
  • 31
    • 0035487814 scopus 로고    scopus 로고
    • Don't ignore the patients
    • Etzwiler DD. Don't ignore the patients. Diab Care 2001;24:1840-1841.
    • (2001) Diab Care , vol.24 , pp. 1840-1841
    • Etzwiler, D.D.1
  • 32
    • 34250019702 scopus 로고    scopus 로고
    • Explaining the decrease in US deaths from coronary disease, 1980-2000
    • Ford ES, Ajani U, Croft J, Crichley J, Labarthe D, et al. Explaining the decrease in US deaths from coronary disease, 1980-2000. N Engl J Med 2007;356:2388-2398.
    • (2007) N Engl J Med , vol.356 , pp. 2388-2398
    • Ford, E.S.1    Ajani, U.2    Croft, J.3    Crichley, J.4    Labarthe, D.5
  • 33
    • 0033926993 scopus 로고    scopus 로고
    • Primary prevention of type 2 diabetes in high-risk populations
    • Harris S, Zinman B. Primary prevention of type 2 diabetes in high-risk populations. Diab Care 2000;23:879-881.
    • (2000) Diab Care , vol.23 , pp. 879-881
    • Harris, S.1    Zinman, B.2
  • 34
    • 34247637288 scopus 로고    scopus 로고
    • International Diabetes Federation: A consensus on type 2 diabetes prevention
    • Alberti KGMM, Zimmet P, Shaw J. International Diabetes Federation: a consensus on type 2 diabetes prevention. Diabet Med 2007;24:451-463.
    • (2007) Diabet Med , vol.24 , pp. 451-463
    • Alberti, K.G.M.M.1    Zimmet, P.2    Shaw, J.3
  • 35
    • 1042302783 scopus 로고    scopus 로고
    • Standards of medical care in diabetes (Position Statement)
    • American Diabetes Association
    • American Diabetes Association. Standards of medical care in diabetes (Position Statement). Diab Care 2004;27(Suppl 1):S15-S36.
    • (2004) Diab Care , vol.27 , Issue.SUPPL. 1
  • 36
    • 0025367559 scopus 로고
    • Cardiovascular risk factors in confirmed prediabetic individuals: Does the clock for coronary heart disease start ticking before the onset of clinical diabetes?
    • Haffner SM, Stern MP, Hazuda HP, Mitchell BD, Patterson JK. Cardiovascular risk factors in confirmed prediabetic individuals: does the clock for coronary heart disease start ticking before the onset of clinical diabetes? JAMA 1990;263:2893-2898.
    • (1990) JAMA , vol.263 , pp. 2893-2898
    • Haffner, S.M.1    Stern, M.P.2    Hazuda, H.P.3    Mitchell, B.D.4    Patterson, J.K.5
  • 37
    • 33846414720 scopus 로고    scopus 로고
    • Guidelines on diabetes, pre-diabetes and cardiovascular diseases: Executive summary
    • The task force on diabetes and cardiovascular diseases of the European Society of Cardiology (ESC) and of the European Association for the Study of Diabetes EASD
    • The task force on diabetes and cardiovascular diseases of the European Society of Cardiology (ESC) and of the European Association for the Study of Diabetes (EASD). Guidelines on diabetes, pre-diabetes and cardiovascular diseases: executive summary. Eur Heart J 2007;28:88-136.
    • (2007) Eur Heart J , vol.28 , pp. 88-136
  • 39
    • 33645104712 scopus 로고    scopus 로고
    • The prevention of overweight and obesity in children and adolescents: A review of interventions and programmes
    • Doak CM, Visscher TLS, Renders CM, Seidell JC. The prevention of overweight and obesity in children and adolescents: a review of interventions and programmes. Obes Rev 2006;7:111-136.
    • (2006) Obes Rev , vol.7 , pp. 111-136
    • Doak, C.M.1    Visscher, T.L.S.2    Renders, C.M.3    Seidell, J.C.4
  • 42
    • 57449101080 scopus 로고    scopus 로고
    • World Health Organization, Ginebra, Suiza: World Health Organization
    • World Health Organization. Non communicable diseases prevention and control. Ginebra, Suiza: World Health Organization, 2006.
    • (2006) Non communicable diseases prevention and control
  • 43
    • 57449093589 scopus 로고    scopus 로고
    • Regional strategy and plan of action on an integrated approach to the prevention and control of chronic diseases, including diet, physical acitivity and health
    • Pan American Health Organization, Pan American Health Organization
    • Pan American Health Organization. Regional strategy and plan of action on an integrated approach to the prevention and control of chronic diseases, including diet, physical acitivity and health. Washington DC, EU: Pan American Health Organization, 2006
    • (2006) Washington DC, EU
  • 44
    • 0028972786 scopus 로고
    • Changes in population cholesterol concentrations and other cardiovascular risk factor levels after 5 years of the noncommunicable disease intervention programme in Mauritius
    • Dowse GK, Gareeboo H, Alberti G, Zimmet P, Tuomilehto-Porran A, Fareed D, et al. Changes in population cholesterol concentrations and other cardiovascular risk factor levels after 5 years of the noncommunicable disease intervention programme in Mauritius. Br Med J 1995;311:1255-1259.
    • (1995) Br Med J , vol.311 , pp. 1255-1259
    • Dowse, G.K.1    Gareeboo, H.2    Alberti, G.3    Zimmet, P.4    Tuomilehto-Porran, A.5    Fareed, D.6
  • 46
    • 33646414505 scopus 로고    scopus 로고
    • How much might achievement of diabetes prevention behaviour goals reduce the incidence of diabetes if implemented at the population level?
    • Simmons RK, Harding AH, Jakes RW. How much might achievement of diabetes prevention behaviour goals reduce the incidence of diabetes if implemented at the population level? Diabetología 2006;49:905-911.
    • (2006) Diabetología , vol.49 , pp. 905-911
    • Simmons, R.K.1    Harding, A.H.2    Jakes, R.W.3
  • 47
    • 84978429960 scopus 로고    scopus 로고
    • Mensah G, Goodman R, Zaza S, Moulton A, Kocher P, Dietz W et al. Law as a tool for preventing chronic diseases: expanding the spectrum of effective public health strategies. Preventing Chronic Disease 2004. [Consultado junio 3, 2007]. Disponible en http://www.cdc.gov/ped/ issues/2004/jan/03_0033. htm.
    • Mensah G, Goodman R, Zaza S, Moulton A, Kocher P, Dietz W et al. Law as a tool for preventing chronic diseases: expanding the spectrum of effective public health strategies. Preventing Chronic Disease 2004. [Consultado junio 3, 2007]. Disponible en http://www.cdc.gov/ped/ issues/2004/jan/03_0033. htm.
  • 48
    • 0037034257 scopus 로고    scopus 로고
    • Reduction in incidence of type 2 diabetes with lifestyle intervention or metformin
    • Diabetes Prevention Program Research Group
    • Diabetes Prevention Program Research Group. Reduction in incidence of type 2 diabetes with lifestyle intervention or metformin. N Engl J Med 2002;346:393-403.
    • (2002) N Engl J Med , vol.346 , pp. 393-403
  • 49
    • 0035799806 scopus 로고    scopus 로고
    • Prevention of type 2 diabetes mellitus by changes in lifestyle among subjects with impaired glucose tolerance
    • Tuomilehto J, Lindstrom J, Eriksson J. Prevention of type 2 diabetes mellitus by changes in lifestyle among subjects with impaired glucose tolerance. N Engl J Med 2001;344:1343-1350.
    • (2001) N Engl J Med , vol.344 , pp. 1343-1350
    • Tuomilehto, J.1    Lindstrom, J.2    Eriksson, J.3
  • 50
    • 14644418458 scopus 로고    scopus 로고
    • A systematic review of drug therapy to delay or prevent type 2 diabetes
    • Pawal R, Majumdar S, Johnson J, Varney J, McAlister F. A systematic review of drug therapy to delay or prevent type 2 diabetes. Diab Care 2005;28:736-744.
    • (2005) Diab Care , vol.28 , pp. 736-744
    • Pawal, R.1    Majumdar, S.2    Johnson, J.3    Varney, J.4    McAlister, F.5
  • 51
    • 34249688687 scopus 로고    scopus 로고
    • Can we prevent type 2 diabetes?
    • Buchanan T. Can we prevent type 2 diabetes? Diabetes 2007;56:1502-1507.
    • (2007) Diabetes , vol.56 , pp. 1502-1507
    • Buchanan, T.1
  • 54
    • 0035487864 scopus 로고    scopus 로고
    • Interventions to improve the management of diabetes in primary care, outpatient, and community settings
    • Renders CM, Valk G, Griffin S, Wagner E, van Eijk JThM, Assendelft WJJ. Interventions to improve the management of diabetes in primary care, outpatient, and community settings. Diab Care 2001;24:1821-1833.
    • (2001) Diab Care , vol.24 , pp. 1821-1833
    • Renders, C.M.1    Valk, G.2    Griffin, S.3    Wagner, E.4    van Eijk, J.T.M.5    Assendelft, W.J.J.6
  • 55
    • 0032885599 scopus 로고    scopus 로고
    • Evaluation of general practice computer templates: Lessons from a pilot randomized controlled trial
    • Shultz EK, Nazareth I, Donegan C, Haines A. Evaluation of general practice computer templates: lessons from a pilot randomized controlled trial. Method Inf Med 1999;38:177-181.
    • (1999) Method Inf Med , vol.38 , pp. 177-181
    • Shultz, E.K.1    Nazareth, I.2    Donegan, C.3    Haines, A.4
  • 56
    • 1242276398 scopus 로고    scopus 로고
    • The North Dublin randomized controlled trial of structured diabetes shared care
    • Smith S, Bury G, O'Leary M, Shannon W, Tynan A, Staines A, et al. The North Dublin randomized controlled trial of structured diabetes shared care. Fam Prac 2004;21:39-46.
    • (2004) Fam Prac , vol.21 , pp. 39-46
    • Smith, S.1    Bury, G.2    O'Leary, M.3    Shannon, W.4    Tynan, A.5    Staines, A.6
  • 59
    • 57449092524 scopus 로고    scopus 로고
    • Prevención de las alteraciones de la conducta alimentaria en grupos específicos: Diabetes mellitus.
    • Pérez A, Barriguete-Meléndez JA, Rivera T. Prevención de las alteraciones de la conducta alimentaria en grupos específicos: diabetes mellitus. Rev Iberoam Psicol 2005;13:84-87.
    • (2005) Rev Iberoam Psicol , vol.13 , pp. 84-87
    • Pérez, A.1    Barriguete-Meléndez, J.A.2    Rivera, T.3
  • 60
    • 20044395091 scopus 로고    scopus 로고
    • The cost-effectiveness of lifestyle modification or metformin in preventing Type 2 diabetes in adults with impaired glucose tolerance
    • Herman W, Hoerger T, Brandle M, Hicks K, Sorensen S, Zhang P, et al. The cost-effectiveness of lifestyle modification or metformin in preventing Type 2 diabetes in adults with impaired glucose tolerance. Ann Intern Med 2005;142:323-332.
    • (2005) Ann Intern Med , vol.142 , pp. 323-332
    • Herman, W.1    Hoerger, T.2    Brandle, M.3    Hicks, K.4    Sorensen, S.5    Zhang, P.6
  • 61
    • 23644454081 scopus 로고    scopus 로고
    • Clinical outcomes and cost-effectiveness of strategies for managing people at high risk for diabetes
    • Eddy D, Schlessinger L, Kahn R. Clinical outcomes and cost-effectiveness of strategies for managing people at high risk for diabetes. Ann Intern Med 2005;143:251-264.
    • (2005) Ann Intern Med , vol.143 , pp. 251-264
    • Eddy, D.1    Schlessinger, L.2    Kahn, R.3
  • 62
    • 35148827614 scopus 로고    scopus 로고
    • Cost-effectiveness of the interventions in primary prevention of diabetes among Asian Indians
    • Ramachandran A, Snehalatha C, Yamuna A, Mary S, Ping Z. Cost-effectiveness of the interventions in primary prevention of diabetes among Asian Indians. Diab Care 2007;30:2548-2552.
    • (2007) Diab Care , vol.30 , pp. 2548-2552
    • Ramachandran, A.1    Snehalatha, C.2    Yamuna, A.3    Mary, S.4    Ping, Z.5
  • 63
    • 0037472879 scopus 로고    scopus 로고
    • Multifactorial intervention and cardiovascular disease in patients with type 2 diabetes
    • Gaede P, Vedel P, Larsen N, Jensen G, Parving H, Pedersen O. Multifactorial intervention and cardiovascular disease in patients with type 2 diabetes. N Engl J Med 2003;348:383-393.
    • (2003) N Engl J Med , vol.348 , pp. 383-393
    • Gaede, P.1    Vedel, P.2    Larsen, N.3    Jensen, G.4    Parving, H.5    Pedersen, O.6
  • 64
    • 33747361000 scopus 로고    scopus 로고
    • Cardiovascular disease with mutiregimen in developing world: A cost-efectiveness analysis
    • Gaziano TA, Opie LH, Weinstein MC. Cardiovascular disease with mutiregimen in developing world: a cost-efectiveness analysis. Lancet 2006;368:679-686.
    • (2006) Lancet , vol.368 , pp. 679-686
    • Gaziano, T.A.1    Opie, L.H.2    Weinstein, M.C.3
  • 65
    • 0033979835 scopus 로고    scopus 로고
    • Can medication packaging improve glycemic control and blood pressure in type 2 diabetes?
    • Simmons D, Upjohn M, Gamble GD. Can medication packaging improve glycemic control and blood pressure in type 2 diabetes? Diab Care 2000;23:153-156.
    • (2000) Diab Care , vol.23 , pp. 153-156
    • Simmons, D.1    Upjohn, M.2    Gamble, G.D.3
  • 66
    • 33847645068 scopus 로고    scopus 로고
    • Impaired fasting glucose and impaired glucose tolerance. Implications for care
    • Nathan D, Davidson M, DeFronzo R, Heine R, Henry R, Pratley R, et al. Impaired fasting glucose and impaired glucose tolerance. Implications for care. Diab Care 2007;30:753-757.
    • (2007) Diab Care , vol.30 , pp. 753-757
    • Nathan, D.1    Davidson, M.2    DeFronzo, R.3    Heine, R.4    Henry, R.5    Pratley, R.6


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.